Trademark Overview
On Wednesday, November 5, 2025, a trademark application was filed for MEZKIXUS with the United States Patent and Trademark Office. The USPTO has given the MEZKIXUS trademark a serial number of 99480962. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, November 5, 2025. This trademark is owned by Celgene Corporation. The MEZKIXUS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Pharmaceutical preparations for the treatment and prevention of Antivirals;; Pharmaceutical preparations for the treatment and prevention of Antibodies for medical purposes;; Pharmaceutical preparations for the treatment and prevention of Anticoagulants;; Pharmaceutical preparations for the treatment and prevention of Radiopharmaceutical preparations for the treatment of cancer and solid tumors;; Pharmaceutical preparations for the treatment and prevention of Diagnostic radiopharmaceutical preparations;; Pharmaceutical preparations for the treatment and pre...
